Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


18.04.2017

1 Alzheimer Dis Assoc Disord
1 Am J Alzheimers Dis Other Demen
2 Am J Geriatr Psychiatry
1 Ann Neurol
2 BMJ
3 J Alzheimers Dis
1 J Am Geriatr Soc
1 J Neural Transm (Vienna)
1 J Neurochem
3 Neurobiol Aging
1 Neurology
1 Neurosci Lett
2 PLoS One
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. DAY GS, Gordon BA, Jackson K, Christensen JJ, et al
    Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia.
    Alzheimer Dis Assoc Disord. 2017 Apr 7. doi: 10.1097/WAD.0000000000000196.
    PubMed     Text format     Abstract available


    Am J Alzheimers Dis Other Demen

  2. KUCUKGUCLU O, Soylemez BA, Yener G, Barutcu CD, et al
    Examining Factors Affecting Caregiver Burden: A Comparison of Frontotemporal Dementia and Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2017 Jan 1:1533317517703479.
    PubMed     Text format     Abstract available


    Am J Geriatr Psychiatry

  3. ROSENBERG PB
    New Insights Into Brain Mechanisms Underlying Neuropsychiatric Symptoms in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Mar 8. pii: S1064-7481(17)30243.
    PubMed     Text format    

  4. GEDA YE, Krell-Roesch J, Sambuchi N, Michel BF, et al
    Neuropsychiatric Symptoms and Neuroimaging Biomarkers in Alzheimer Disease: "Which is the Cart and Which is the Horse?"
    Am J Geriatr Psychiatry. 2017 Mar 16. pii: S1064-7481(17)30256.
    PubMed     Text format    


    Ann Neurol

  5. MENG Y, Volpini M, Black S, Lozano AM, et al
    Focused ultrasound as a novel strategy for Alzheimer's disease therapeutics.
    Ann Neurol. 2017 Apr 10. doi: 10.1002/ana.24933.
    PubMed     Text format     Abstract available


    BMJ

  6. WISE J
    Vascular risk factors show link to development of Alzheimer's.
    BMJ. 2017;357:j1847.
    PubMed     Text format    

  7. HAWKES N
    Sixty seconds on . . . solanezumab.
    BMJ. 2016;355:i6389.
    PubMed     Text format    


    J Alzheimers Dis

  8. YUAN XZ, Sun S, Tan CC, Yu JT, et al
    The Role of ADAM10 in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 10. doi: 10.3233/JAD-170061.
    PubMed     Text format     Abstract available

  9. REDDY PH
    A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 10. doi: 10.3233/JAD-170256.
    PubMed     Text format     Abstract available

  10. REDDY PH, Manczak M, Yin X
    Mitochondria-Division Inhibitor 1 Protects Against Amyloid-beta induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 10. doi: 10.3233/JAD-170051.
    PubMed     Text format     Abstract available


    J Am Geriatr Soc

  11. EZZATI A, Wang C, Lipton RB, Altschul D, et al
    Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology.
    J Am Geriatr Soc. 2017 Apr 13. doi: 10.1111/jgs.14903.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  12. HINTERBERGER M, Fischer P, Huber K, Krugluger W, et al
    Leukocyte telomere length is linked to vascular risk factors not to Alzheimer's disease in the VITA study.
    J Neural Transm (Vienna). 2017 Apr 9. doi: 10.1007/s00702-017-1721.
    PubMed     Text format     Abstract available


    J Neurochem

  13. ARENDT T, Stieler J, Ueberham U
    Is sporadic Alzheimer's disease a developmental disorder?
    J Neurochem. 2017 Apr 11. doi: 10.1111/jnc.14036.
    PubMed     Text format     Abstract available


    Neurobiol Aging

  14. BOSCIA F, Pannaccione A, Ciccone R, Casamassa A, et al
    The expression and activity of KV3.4 channel subunits are precociously upregulated in astrocytes exposed to Abeta oligomers and in astrocytes of Alzheimer's disease Tg2576 mice.
    Neurobiol Aging. 2017 Mar 16. pii: S0197-4580(17)30079.
    PubMed     Text format     Abstract available

  15. WALKER DG, Lue LF, Tang TM, Adler CH, et al
    Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not alpha-synuclein pathology.
    Neurobiol Aging. 2017 Mar 16. pii: S0197-4580(17)30078.
    PubMed     Text format     Abstract available

  16. TAO QQ, Liu ZJ, Sun YM, Li HL, et al
    Decreased gene expression of CD2AP in Chinese patients with sporadic Alzheimer's disease.
    Neurobiol Aging. 2017 Mar 16. pii: S0197-4580(17)30084.
    PubMed     Text format     Abstract available


    Neurology

  17. NG KP, Pascoal TA, Mathotaarachchi S, Chung CO, et al
    Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
    Neurology. 2017 Apr 12. pii: 10.1212/WNL.0000000000003916.
    PubMed     Text format     Abstract available


    Neurosci Lett

  18. KUNKLE BW, Carney RM, Kohli MA, Naj AC, et al
    Targeted sequencing of ABCA7 identifies splicing, stop-gain and intronic risk variants for Alzheimer disease.
    Neurosci Lett. 2017 Apr 8. pii: S0304-3940(17)30305.
    PubMed     Text format     Abstract available


    PLoS One

  19. VAN GIJSEL-BONNELLO M, Baranger K, Benech P, Rivera S, et al
    Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.
    PLoS One. 2017;12:e0175369.
    PubMed     Text format     Abstract available

  20. KASAI T, Kondo M, Ishii R, Tanaka A, et al
    Abeta levels in the jugular vein and high molecular weight Abeta oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease.
    PLoS One. 2017;12:e0174630.
    PubMed     Text format     Abstract available


    Rev Neurol (Paris)

  21. DUBOURG L, Silva AR, Fitamen C, Moulin CJ, et al
    SenseCam: A new tool for memory rehabilitation?
    Rev Neurol (Paris). 2016;172:735-747.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: